New paper
Testis-Specific MAGEA3/6 Regulate Glycolysis to Promote Metabolic Flexibility and Reveal Therapeutic Vulnerabilities in Pancreatic Cancer Cells
Why it was picked newest record on or before this date
The Pancreatic Cancer Research Digest
New trials, papers and changes to existing records, compiled daily from the public registries
10 items · 0 changes to existing records
New paper
Oncogenic KRAS-MAPK signaling sustains a CD73 dependent therapeutic vulnerability in pancreatic cancer
Why it was picked newest record on or before this date
New paper
Bremachlorin-Based Photodynamic-Therapy-Induced Effects in Low-Oxygenated Pancreatic Ductal Adenocarcinoma (PDAC) Tumor Microenvironment.
Why it was picked newest record on or before this date
New paper
The sensitivity of decision support tools for identifying patients with pancreatic cancer: an observational study.
Why it was picked newest record on or before this date
New paper
Immunohistochemical Expression of M30, BCL-2, BAX, and Ki-67 in Pancreatic Ductal Adenocarcinoma: Association with Clinicopathological Features.
Why it was picked newest record on or before this date
Also today
New paper
Context-Dependent Spatial and Functional Roles of CD44 Across Pancreatic Ductal Adenocarcinoma States.
New paper
Mevalonate Biosynthesis is a Metabolic Vulnerability of Gemcitabine-resistant Pancreatic Cancer.
New paper
Reprogramming tumor-associated macrophages via ID3 mRNA delivery for enhanced immunotherapy in pancreatic cancer.
New paper
NEIL2 regulates RNA polymerase II dynamics to suppress transcription–replication conflicts in pancreatic cancer
Editor’s note
Not in the data yet: changes to existing records. Status changes, newly posted results and retractions need a history of each record, which is not collected yet. Until then the digest lists new records only.
Compiled by the knowledge layer from its change log. Every headline opens the underlying record; every identifier links to its source.